Live Breaking News & Updates on Clinuvel pharmaceuticals stock performance

Stay informed with the latest breaking news from Clinuvel pharmaceuticals stock performance on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Clinuvel pharmaceuticals stock performance and stay connected to the pulse of your community

Clinuvel Pharmaceuticals Limited (ASX:CUV) Insider Philippe Wolgen Acquires 1,850 Shares

Clinuvel Pharmaceuticals Limited (ASX:CUV – Get Free Report) insider Philippe Wolgen acquired 1,850 shares of the firm’s stock in a transaction that occurred on Tuesday, September 19th. The shares were purchased at an average price of A$16.12 ($10.40) per share, with a total value of A$29,812.75 ($19,234.03). Philippe Wolgen also recently made the following trade(s): […]

Switzerland , United-states , Australia , Philippe-wolgen , Clinuvel-pharmaceuticals-increases-dividend , Clinuvel-pharmaceuticals-limited , Clinuvel-pharmaceuticals-stock-performance , Clinuvel-pharmaceuticals-company-profile , News-ratings-for-clinuvel-pharmaceuticals-daily , Clinuvel-pharmaceuticals , Get-free-report , Pharmaceuticals-limited